Organizations Filed Purposes:
1) DEVELOPMENT & VALIDATION OF NEW MEASURES 2) TRANSLATION & ADAPTION OF TOOLS FOR USE IN INTERNATIONAL RESEARCH 3) TECHNICAL ASSISTANCE IN SUPPORT OF PATIENT -BASED TOOLS IN A VARIETY OF SPECIFIC APPLICATIONS 4) EDUCATION & TRAINING IN PATIENT REPORTED OUTCOMES.
RESEARCH & DEVELOPMENT OF HEALTH OUTCOMES IN FIELD OF HEALTH CARE SERVICES
HEALTH ASSESSMENT LAB (HAL) IS A RESEARCH CENTER THAT WORKS WITH A NETWORK OF U.S. AND INTERNATIONAL RESEARCHERS. HAL'S ACTIVITIES FOCUS ON THE WORLDWIDE ADVANCEMENT OF PATIENT-BASED HEALTH STATUS ASSESSMENT THROUGH: (1) DEVELOPMENT OF HIGHLY EFFICIENT SURVEY METHODS FOR ASSESSING HEALTH OUTCOMES FROM THE PATIENT'S POINT OF VEIW; (2) TRANSLATION AND VALIDATION OF HEALTH STATUS QUESTIONNAIRES; (3) PROVISION OF TECHNICAL ASSISTANCE TO USERS OF THE QUESTIONNAIRES; AND (4) EDUCATIONAL OUTREACH. IN PARTICULAR, HAL IS WELL-KNOWN FOR ITS WORK WITH SF-36R AND SF-12R HEALTH SURVEYS, WHICH ARE THE MOST WIDELY-USED PATIENT-BASED HEALTH STATUS QUESTIONNAIRES IN THE WORLD. THE PRODUCT OF HAL'S RESEARCH ARE USED IN CLINICAL RESEARCH, CLINICAL PRACTICE AND POPULATION MONITORING.IN JUNE 2010, THE ORGANIZATION'S BOARD OF DIRECTORS ANNOUNCED THE ESTABLISHMENT OF THE ALVIN R. TARLOV AND JOHN E. WARE, JR. (TARLOV/WARE) DOCTORAL DISSERTATION AWARD IN PATIENT REPORT OUTCOMES. IN 2011, THE ORGANIZATION'S BOARD ESTABLISHED THE TARLOV/WARE POST DOCTORAL AWARD PROGRAM IN PATIENT REPORTED OUTCOMES. THE PURPOSE OF THESE AWARDS IS TO ENCOURAGE DOCTORAL DISSERTATIONS AND POST DOCTORAL STUDIES ON PATIENT REPORTED OUTCOMES. IN 2016, THE BOARD ESTABLISHED THE TARLOV/WARE CAREER ACHIEVEMENT PROGRAM, WHICH WILL BE AWARDED ANNUALLY DURING THE PLENARY SESSION OF THE INTERNATIONAL SOCIETY IN HEALTHCARE (ISQUA) ANNUAL MEETING, & AGREED TO SUPPORT AN ANNUAL PRE-CONFERENCE WORKSHOP ON PATIENT REPORTED OUTCOMES. THE ORGANIZATION AWARDED EDUCATIONAL/RESEARCH GRANTS TOTALING $72,900 AND $103,400 FOR THE YEARS ENDED DECEMBER 31, 2019 AND 2018, RESPECTIVELY. THE ORGANIZATION AWARDED EDUCATIONAL/RESEARCH GRANTS FROM CYSTIC FIBROSIS FOUNDATION TOTALING $4,138 FOR THE YEAR ENDED DECEMBER 31, 2019.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Dr Michael Zubkoff | DIRECTOR & CEO, CSO | 6 | $153,414 |
| Dr Eugene Nelson | DIRECTOR & CEO, CSO | 6 | $115,059 |
| Zach E Nelson | DIRECTOR OF COMMUNICATIONS | 20 | $51,051 |
| Mr Lucas Nelson | DIRECTOR | 1 | $0 |
| Dr Lisa Zubkoff | DIRECTOR | 3 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202033169349303543_public.xml